AGP Executive Report
Last update: 12 hours agoFDA Approval for Rare Disease: Mirum Pharmaceuticals and Incyte say the U.S. FDA approved Atebrioz (zilurgisertib) tablets for adults and pediatric patients age 12+ with fibrodysplasia ossificans progressiva (FOP), aiming to reduce new heterotopic ossification. Delaware Court on Workers’ Comp: The Delaware Supreme Court upheld denial of workers’ compensation benefits, deferring to the Industrial Accident Board’s findings on witness credibility and medical testimony. Health Data Privacy Push: Delaware is among states expanding privacy rules as federal action stalls, with new requirements focused on sensitive health data and stronger vendor due diligence. Medicaid Funding Fight: Delaware Attorney General Aaron D. Ford joined a coalition opposing a proposed federal rule that could put Medicaid funding at risk and interfere with state health insurance oversight. Measles Warning: A new national measles update shows cases rising, with Delaware listed among jurisdictions reporting infections—another reminder to stay up to date on vaccines as flu season approaches. Public Safety Funding: FEMA announced more than $47M in federal grants to fire and emergency response organizations across several states, including Delaware-area responders.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
